Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minuteThe 2020 announcement commonly described as a DXC “spin-off” was ultimately a sale of DXC’s U.S. State and Local Health and Human Services business to Veritas Capital. The business was renamed Gainwell Technologies, and the transaction closed on October 1, 2020.
DXC announced the planned separation on September 16, 2020. Veritas agreed to acquire the unit for approximately $5 billion, and then-DXC chief financial officer Paul Saleh was named to become Gainwell’s chief executive after closing. Contemporary coverage used the term “spin-off,” but DXC’s later regulatory filing records the transaction as a divestiture and sale.
As an Amazon Associate I earn from qualifying purchases.
What DXC separated
The transaction involved DXC’s U.S. State and Local Health and Human Services business, which DXC referred to in later filings as the HHS Business. It served government and human-services programs rather than representing all of DXC’s public-sector or healthcare operations.
Free tools Windows power users keep installed
One-click scans. No signup required.
That distinction matters. The deal did not separate all of DXC’s government contracts, all of its healthcare activities, or its broader enterprise IT-services business. It concerned the specific state and local health and human-services operation that became Gainwell Technologies.
#1 Best Overall
Who bought the business?
Veritas Capital, a private-equity investment firm, agreed to acquire the business. Gainwell Technologies was the name under which the acquired operation was intended to operate; Gainwell was not the buyer.
Veritas said the Gainwell name was meant to reflect a commitment to improving health outcomes in the United States through technology and support. That was the buyer’s stated branding rationale, not an independent assessment of the company’s subsequent performance.
Announcement and closing dates
| Date | Event |
|---|---|
| March 2020 | Veritas’ agreement to acquire the business was announced, according to contemporary reporting. |
| September 16, 2020 | DXC’s planned separation, Gainwell name, and leadership plans were reported. |
| October 1, 2020 | The sale was completed and the business became Gainwell Technologies. |
The September announcement and October completion should not be treated as the same event. DXC’s later Form 10-K confirms October 1, 2020, as the closing date.
How large was the deal?
Contemporary reports described the transaction as being worth approximately $5 billion. DXC’s later filing gives the figure as $5.0 billion in total enterprise value.
Enterprise value is not automatically the same as cash proceeds paid directly to DXC or the amount received by DXC shareholders. The reported value was subject to net-working-capital adjustments and included assumed liabilities. DXC also disclosed a future-services component of approximately $85 million, reflecting services that DXC would provide after the transaction.
For that reason, describing the deal simply as a “$5 billion cash sale” would overstate what the filing establishes.
Rank #3
Why did DXC divest the business?
The transaction formed part of DXC’s broader portfolio-shaping strategy. Contemporary reporting connected the divestiture with efforts to strengthen DXC’s finances and concentrate the company more heavily on its core enterprise technology-services operations.
That explanation should be understood as a description of DXC’s strategy and the period’s reporting, rather than as proof of every management consideration behind the deal. The verified result is that DXC sold the HHS business to Veritas and removed it from DXC’s continuing portfolio.
Why “spin-off” is an imprecise description
In media coverage: “Spin-off” was used as shorthand for separating the business from DXC and giving it a new identity.
Rank #4
- Used Book in Good Condition
In DXC’s later filing: the transaction is described as the sale of the HHS Business to Veritas Capital to form Gainwell Technologies.
A conventional public-company spin-off usually involves distributing shares of a newly independent company to the parent company’s shareholders. The reviewed sources do not establish that DXC shareholders received Gainwell shares. The more precise description is therefore: DXC’s planned separation was completed as a sale to Veritas Capital, with the business operating under the Gainwell Technologies name.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Who was expected to lead Gainwell?
Paul Saleh, then DXC’s executive vice president and chief financial officer, was named to become Gainwell’s CEO after the transaction closed. This is a historical description of the 2020 leadership plan and should not be read as a statement about Gainwell’s current leadership.
How this differed from Perspecta
DXC had also separated its former U.S. public-sector business in an earlier transaction that resulted in Perspecta. That was a different business and a different transaction.
Both deals involved government-related operations, but Gainwell came from DXC’s U.S. State and Local Health and Human Services business and was acquired by Veritas Capital. It should not be conflated with the Perspecta separation or with DXC’s remaining enterprise-services operations.
What the headline means today
The headline refers to a completed 2020 corporate transaction, not a pending spin-off. The business involved was separated from DXC, acquired by Veritas Capital, and renamed Gainwell Technologies on October 1, 2020.
The sources supporting this historical explanation do not establish Gainwell’s current ownership, leadership, contracts, revenue, or corporate structure as of 2026. Those details require newer company or regulatory sources and should not be inferred from the original announcement or DXC’s 2022 filing.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
